Behind the prescription outflow: challenges and opportunities for hospital side stores
A few days ago, the Heilongjiang Provincial Drug Administration issued the "Implementation Plan for the Inspection of the Business Quality of Drug Retail Enterprises around Hospitals" (hereinafter referred to as the "Plan"), requiring drug regulatory authorities around the region to organize a one-month supervision and inspection of drug retail enterprises around hospitals under their jurisdiction, especially the tertiary hospitals. In this regard, the drug retail enterprises around hospitals (hereinafter referred to as "hospital-side stores"), which have been extremely hot in recent years, have been brought to the attention of the industry again. At present, although there are various problems in the hospital side stores, but with the promotion of prescription outflow and the development of the out-of-hospital market, its future is still promising. For pharmaceutical companies, they must do a good job of targeted marketing in order to seize the first opportunity in the hospital side store market.
2026-10-18
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
Biocytogen announces the launch of the 'Nano 100 Project' to develop fully human therapeutic nanobodies against 100+ targets
-
Wantai Biotech 20-valent pneumonia vaccine started clinical trials, how far is domestic substitution?
-
Yiming Cell 'Suspension 293XS Cell Bank' completed DMF filing with the US FDA
-
The phase III clinical study of Junshi Biologics in combination with teripulimab in the treatment of advanced triple-negative breast cancer reached the primary endpoint
-
The next bombshell: 'PD-1 + ADC', Kelun, Hengrui are going to win numbness?
-
L-Rotator Biotech completed its pre-A financing and continued to increase its investment in the CGT field
-
Hainan to promote drug import facilitation
-
Enable the 'export of EU APIcertification documents' and 'pharmaceutical export salescertificate' electronic proof
-
China to focus on building quality and efficient TCM service system in next five years
Recommend Reading
-
India Approves ₹30.3 Billion Chemical-Park Scheme to Build Three Mega Industrial Hubs
-
EFSA’s Updated Food-Additive Application Guidance Takes Effect
-
FDA Revokes Orange B Authorization and Proposes Removing Citrus Red No. 2
-
US Pushes G20 to Reassess Trade with China, Raising New Risks for Chemical Exporters
-
Sudden Turmoil in Middle East Shipping Routes: Multiple Carriers Announce Emergency Navigation and Surcharge Policies
-
Geopolitical Conflict Conduction, Butanol Prices in China Increased by Over 7% in Three Days
-
Geopolitical and Cost Factors Drive Short-Term Strength in Melamine in China
-
Middle East Geopolitical Tensions Intensify, China's SC Crude Oil Futures See Significant Premium Over Brent and WTI
-
Geopolitical Conflicts Reignite, Why Lithium Carbonate Has Not Shown the Same Frenzy as 4 Years Ago in China
-
In March, the Cost Pressure of Hydrofluoric Acid and Rigid Demand Compete, Market Prices Slightly Increase